Amgen Inc (AMGN)

238.450
+1.050(+0.44%)
  • Volume:
    69
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    235.100 - 238.450
  • Type:Equity
  • Market:Austria
  • ISIN:US0311621009

AMGN Overview

Prev. Close
186.46
Day's Range
235.1-238.45
Revenue
-
Open
235.1
52 wk Range
174.54-237.4
EPS
-
Volume
69
Market Cap
126.72B
Dividend (Yield)
7.76
(3.03%)
Average Volume (3m)
59
P/E Ratio
-
Beta
-
1-Year Change
19.62%
Shares Outstanding
534,199,933
Next Earnings Date
-
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24300

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy